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Abstract  69 
Scope: Hydroxytyrosol (HT) is the major phenolic compound in virgin olive oil (VOO) 70 
that may exert health benefits against atherosclerosis. The native form of HT is 71 
undetectable in plasma due to an extensive first pass phase II metabolism. Therefore, it 72 
is necessary to find strategies to obtain HT metabolites and to demonstrate their 73 
protective role against the endothelial dysfunction. 74 
Methods and results: Biosynthesis of the main plasmatic HT metabolites was 75 
performed through Caco-2 cells. The bioactivity of HT and the mixture of metabolites 76 
was tested at physiological concentrations (1, 2, 5 and 10 µM) in human aortic 77 
endothelial cells (HAEC) co-incubated with TNF-α (10 ng/mL) for 18 and 24 h. After 78 
the incubations, cells and media were analyzed to test possible deconjugation of 79 
metabolites or conjugation of HT. Both HT and HT metabolites significantly reduced 80 
the secretion of E-selectin, P-selectin, ICAM-1 and VCAM-1, but only HT metabolites 81 
further reduced MCP-1 at 24 h. HT underwent a conjugation process after incubation 82 
leading to its main metabolites in a dose-dependent manner. 83 
 Conclusion: Physiological HT metabolites, synthetized for the first time by using an 84 
intestinal cell model, might be the responsible in part for the protection against 85 
endothelial dysfunction.  86 
87 
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1. Introduction 88 
Virgin olive oil (VOO) a key component of the Mediterranean Diet (MD) has shown to 89 
contribute to cardiovascular disease (CVD) prevention. Part of this effect has been 90 
associated to VOO phenolic content [1,2]. Results from the PREDIMED study, the first 91 
randomized clinical trial designed to assess the beneficial effects of the MD on the 92 
primary prevention of CVD, reported that the MD supplemented with VOO has a dual 93 
effect on the prevention of CVD, reducing classical cardiovascular risk factors and also 94 
having an intense anti-inflammatory effect through the down-regulation of endothelial 95 
dysfunction markers related to atherosclerosis, such as vascular cell adhesion molecule-96 
1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E- and P-Selectin [3]. 97 
 Hydroxytyrosol (HT) is the major phenolic compound in VOO in both free and 98 
conjugated form, mainly as oleuropein aglycone structures commonly named 99 
secoiridoids. HT has shown showing a wide range of biological functions, such as 100 
antioxidant, anticancer, anti-inflammatory, and neuroprotective activities, as well as 101 
having beneficial effects on the cardiovascular system [4,5]. The potential health 102 
benefits of HT have stimulated intense research on the bioavailability and metabolism 103 
of VOO phenolic compounds, a requisite to support their potential benefits for human 104 
health. Previous studies have shown that VOO phenolic compounds undergo rapid 105 
hydrolysis under gastric and intestinal alkaline conditions resulting in significant 106 
increases in the amount of free HT entering the small intestine [6,7]. Thus, HT becomes 107 
the major phenolic compound absorbed from the intestinal tract, which is further 108 
subjected to an extensive first pass metabolism, both in the intestinal epithelium and the 109 
liver, leading to the formation of phase II metabolites, mainly sulfate, methyl and 110 
methyl-sulfate conjugates and glucuronides of HT [8–11]. 111 
Consequently, after the consumption of normal doses of VOO (less than 50 g / day) the 112 
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native form of HT is not detected in plasma and the potential health benefits of VOO 113 
phenolic compounds could be either attributed to the biological activity of phase II 114 
metabolites or to free HT generated at cellular level by enzymatic deconjugation. So, it 115 
becomes essential to obtain the plasmatic HT metabolites, and test them in cell-based 116 
experimental models at physiological concentrations and examine a possible 117 
deconjugation process of these metabolites at the cellular level. 118 
The physiological significance of most of the published articles on polyphenols 119 
bioactivity has been questioned as they still describe the effects of molecules that are 120 
only present in planta or in food. Nevertheless, detailed studies applying plasmatic and 121 
microbial metabolites of phenolic compounds are starting to establish reasonable 122 
mechanisms through which these physiological metabolites may exert beneficial effects 123 
[12]. In the case of VOO phenolics, a previous study tested the in vitro radical 124 
scavenging capacity of some of the HT metabolites observing that homovanillic alcohol 125 
(HVAlc) and the 3-O-glucuronide conjugate appeared to be active in terms of 126 
antioxidant activity [13].  However, further observations suggested that none of the 127 
glucuronide conjugates of HT displayed antioxidant activity to protect LDL against 128 
oxidation [14]. 129 
Regarding the antiatherogenic effects, only HT in its native form has been tested 130 
on preclinical experimental models describing its protective effects against 131 
atherosclerosis [15,16] and no data has been published in relation to its biological 132 
metabolites. As reported by Valls et al., these metabolites could be involved in reducing 133 
the endothelial dysfunction in humans [17]. However, the mechanisms have not been 134 
demonstrated.   135 
 Endothelial dysfunction is involved in the early stages of atherosclerosis and is a 136 
key process in the development of CVD [18]. Briefly, the endothelial dysfunction in the 137 
Page 6 of 36
Wiley-VCH
Molecular Nutrition and Food Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
7 
 
early stages of atherosclerosis includes rolling (mediated by E- and P-selectin) and firm 138 
adhesion (mediated by VCAM-1 and ICAM-1) of blood leukocytes to the activated 139 
endothelial monolayer and directed migration (mediated by the monocyte chemotactic 140 
protein-1; MCP-1) of the bound leukocytes into the intima [18,19]. So the endothelial 141 
dysfunction biomarkers E-selectin, P-selectin, VCAM-1, ICAM-1 and MCP-1 were 142 
selected in the present study as they have been considered as useful predictive 143 
biomarkers of atherosclerosis [20]. The surface and soluble expression of these 144 
molecules is greatly increased in atherosclerotic lesions as a result of stimulation by 145 
pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). This cytokine 146 
was used in the present study as a stressor molecule for assessing the underlying 147 
mechanisms as it induces the release and surface expression of cell adhesion molecules 148 
[21,22].  149 
 So, the main aim of the present study was to optimize the use of Caco-2 cell line 150 
as an alternative approach to obtain biological metabolites of HT previously detected in 151 
human plasma, and to evaluate their in vitro endothelial protective effect compared to 152 
HT alone at physiological concentrations [10]. 153 
2. Material and methods 154 
2.1. Solvents and reagents 155 
HT (99.51% of purity, synthetic) was provided by Seprox Biotech (Madrid, Spain). 156 
Catechol, as the internal standard, (IS) was purchased from Sigma-Aldrich (St. Louis, 157 
MO, USA). Hydroxytyrosol-3-O-sulfate was custom-synthesized by Toronto Research 158 
Chemicals Inc. (Toronto, ON, Canada). Methanol (HPLC-grade), acetonitrile (HPLC-159 
grade), ethanol and dimethyl sulfoxide (DMSO) were purchased from Scharlab 160 
(Barcelona, Spain) and orthophosphoric acid (85%) from Panreac (Barcelona, Spain). 161 
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Milli-Q water was obtained from a Milli-Q water purification system (Millipore Corp., 162 
Medford, MA, USA).  163 
2.2. Caco-2 cell culture treatments to obtain HT metabolites 164 
Caco-2 cell line was purchased from ATCC (American Type Culture Collection, US). 165 
Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose 166 
(HyClone, Thermo scientific, Logan, Utah) supplemented with 10% of fetal bovine 167 
serum (Sigma-Aldrich, Madrid, Spain), 1% L-glutamine (HyClone, Thermo scientific, 168 
Logan, Utah), 1% (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) 169 
(HyClone, Thermo scientific, Logan, Utah), penicillin and streptomycin (100mg/mL) 170 
(Gibco, Spain). Cells were cultured at 37°C, in a 5% CO2 humidified incubator. Media 171 
culture was replaced every 2 days and phosphate buffered saline (PBS; HyClone, 172 
Thermo Scientific, Logan, Utah) was used to wash the cells. In preliminary 173 
experiments, the stability of HT was evaluated over time (6, 12, 24 and 48 h) with 174 
DMEM or Hanks’ Balanced Salt Solution (HBSS; HyClone, Thermo scientific, Logan, 175 
Utah) media and finally, HBSS was chosen to perform all the experiments due to a 176 
better stability of HT over the time in these media. 177 
In order to select the optimal cell treatment to obtain HT metabolites, T75 flask 178 
and transwell inserts (both from Corning Costar, Netherlands) ere tested as two 179 
different culture conditions (Figure 1A). On the one hand, Caco-2 cells were seeded in 180 
T75 flasks at a density of 6.6 x 104 cells/mL and their HT conjugation rate was 181 
evaluated at two differentiation states: three days after seeding (A treatment) or after 21 182 
days of culture (B treatment). On the other hand, Caco-2 cells were seeded in the apical 183 
side of transwell inserts at a density of 4.6 x 104 cells/mL and cultured for 21 days (C 184 
treatment). D treatment consisted of 18 days of Caco-2 culture (4.6 x 104 cells/mL) in 185 
the apical side of transwell inserts and, after 18 days, an additional co-culture of Caco-2 186 
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cells was seeded in the basolateral side (5 x 104 cells/ mL) for three more days, making 187 
a total of 21 days. Monolayer formation in transwell inserts was evaluated by 188 
transepithelial electrical resistance (TEER) measurement  with a voltohmmeter 189 
(Millipore Corp., MA) selecting cells with TEER > 250 Ω/ cm2. For all treatments (A, 190 
B, C and D), the initial concentration of HT in the culture medium was 100 µM (HT 191 
stock solution 100 mM in methanol) and three exposure times were tested (6, 12 and 24 192 
h). To preempt cytotoxicity, methanol concentrations never exceeded 0.1% (v/v) in 193 
culture media. Finally, supernatants of T75 flasks (A and B treatments) and the sum of 194 
the apical and basolateral supernatants from transwell inserts (C and D treatments) were 195 
collected. Prior to chromatographic analysis (see section 2.4), HT and its metabolites 196 
were extracted from the cell media using micro-elution solid-phase extraction (µSPE) 197 
plates with OASIS HLB µElution Plates 30 µm (Waters Corp., Milford, MA, USA) 198 
according to the previous study [23].  199 
After the selection of 21-day cultured cells in T75 flasks with 24 h of HT 200 
incubation (B treatment) as the optimal treatment (see section 3.2), different HT 201 
concentrations (10, 15, 20, 25, 50 and 100 µM) in the culture medium were assayed in 202 
order to test the effect of the HT concentration on the transformation yield of HT into its 203 
metabolites.  204 
2.3. Purification of HT metabolites from Caco-2 culture medium  205 
Once the B treatment (21-day cultured cells in T75 flasks) incubated with 100 µM HT 206 
for 24 h was selected as the optimal treatment for obtaining HT metabolites, the µSPE 207 
plates were replaced by SPE cartridges with a higher sorbent size (OASIS HLB Elution 208 
Plates 6 g, 35 cc, Waters, Milford, MA, USA) to obtain major amounts of HT 209 
metabolites. The conditioning of the SPE cartridges was done by adding sequentially 35 210 
mL of methanol and 40 mL of milli-Q water acidified at pH 2 with acetic acid (Figure 211 
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1B). Extractions were done by loading 50 mL of Caco-2 supernatant, which had been 212 
previously mixed with 50 mL of phosphoric acid at 4%. The loaded cartridges were 213 
washed with 30 mL of milli-Q water and 20 mL of methanol 5%. Finally, the retained 214 
phenolic compounds were eluted using 60 mL of methanol (100%). This elution solvent 215 
was evaporated to dryness under a nitrogen stream in an evaporating unit at 30 ºC 216 
(PIERCE Model 18780, IL, USA). In order to obtain a more concentrated solution, after 217 
evaporation, eluates from several cartridges were collected and consecutively 218 
evaporated in the same tube. The residue was reconstituted with 1mL of methanol. The 219 
extract was filtered through a 0.22 µm nylon syringe filter (Teknokroma, Barcelona, 220 
Spain) and transferred to the autosampler vial before the quantification of HT 221 
metabolites by liquid chromatography.  This stock solution of HT metabolites was used 222 
to study their effectivity on endothelial dysfunction model in HAEC.  223 
2.4. Chromatographic analysis of HT metabolites 224 
HT metabolites were analyzed by AcQuity UPLCTM coupled to PDA detector and a 225 
triple quadrupole detector (TQD)TM mass spectrometer (Waters, Milford, MA, USA). 226 
The analytical column was a High Strength Silica (HSS) T3 column (100 x 2.1 mm, 1.8 227 
µm). During the analysis, the column was kept at 30 ºC and the flow rate was 0.3 228 
mL/min using 0.2% acetic acid as solvent A and methanol as solvent B. The elution 229 
started at 3% of eluent B and was linearly increased to 15% of eluent B in 6 min. Then, 230 
it was linearly increased to 70 % in 8 min and further increased to 100 % in 3 min. 231 
Then, it was returned to the initial conditions in 1 min, and the re-equilibration time was 232 
2 min. The injection volume was 2.5 µL. 233 
A triple quadrupole detector (TQD)TM mass spectrometer was used as the 234 
detector system. Ionization was done by electrospray (ESI) in the negative mode and the 235 
data were collected in the selected reaction monitoring (SRM) mode. The ionization 236 
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source parameters were capillary voltage of 3 KV, source temperature of 150 ºC, and 237 
desolvation temperature of 400 ºC with a flow rate of 800 L/h. Nitrogen (99% purity, 238 
N2LCMS nitrogen generator, Claind, Como, Italy) and argon (≥99.99% purity, 239 
Aphagaz, Madrid, Spain) were used as the cone and collision gases, respectively. Two 240 
transitions were acquired for HT and the metabolites generated, one for quantification 241 
and a second for confirmation purposes. The optimized SRM conditions are presented 242 
in Table S1 of Supporting Information. The software used was MassLynx 4.1. HT 243 
and HT-3-O-sulphate were quantified with their own calibration curves, and the other 244 
HT metabolites were tentatively quantified by using the calibration curve of HT. The 245 
calibration curves were constructed by using cellular medium free of HT metabolites. 246 
2.5. HAEC cell culture for testing HT and HT metabolites activity 247 
HAEC (Cascade Biologics™, Portland, Oreg., USA) at the 5th passage were seeded on 248 
Nunclon™ ∆ surface 12-well plates at a density of approximately 44*103 of viable 249 
cells/mL (1 mL / well). For the first 24 h, cells were maintained in complete cell culture 250 
medium (CM) composed of M-200 medium supplemented with 2% (v/v) low-serum 251 
growth supplement, 10 mg/mL gentamicin, 0.25 mg/ml amphotericin B (purchased 252 
from Gibco by Life Technologies, Madrid, Spain), 100 U/mL penicillin and 100 mg/mL 253 
of streptomycin (from Biowest-Labclinics, Barcelona, Spain). The cells were grown to 254 
confluence at 37°C in a humidified incubator (Heracell 150; Madrid, Spain) with an 255 
atmosphere containing 5% CO2. The medium was replenished every 2 days with fresh 256 
CM. Viewed under an IMT2 microscope (Olympus, Barcelona, Spain), confluent 257 
monolayers displayed a typical monolayer phenotype of quiescent endothelial cells after 258 
5 days in culture.  259 
Experiments of time and dose-response were conducted in order to establish the 260 
final conditions of TNF-α as a stimulant. Stock solutions used for the experiments were: 261 
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5 mM of HT (commercial) dissolved in sterile H2O and 10 mM of the purified solution 262 
of HT metabolites dissolved in methanol (Panreac, Madrid, Spain). Appropriate 263 
dilutions were prepared until the final concentrations to be tested in the culture media 264 
(1, 2, 5 and 10 µM) were obtained. To preempt cytotoxicity, methanol concentrations 265 
never exceeded 0.1% (v/v) in culture media. Then, HAEC were co-incubated with HT 266 
or HT metabolites at 1, 2, 5 and 10 µM and TNF-α (10 ng/mL; Calbiochem, Darmstadt, 267 
Germany), the respective vehicle control alone (sterile H2O for HT or absolute methanol 268 
for HT metabolites) or TNF-α alone (10 ng/mL) for 18 or 24h. Additional experiments 269 
were performed to test HT at lower concentrations (<1 µM) equivalent to 9% of the 270 
residual HT remaining in the HT metabolites mixture at the concentrations tested (0.09, 271 
0.18, 0.45 and 0.9 µM). 272 
After co-incubation, supernatants were collected and stored at –20°C for batched 273 
measurements of the soluble forms of the selected cell adhesion molecules (VCAM-274 
1/CD106, E-selectin/CD62E, P-selectin/CD62P and ICAM-1/CD54) or chemokine 275 
(MCP-1/CCL2) and for the activity of the lactate dehydrogenase (LDH) released. Cells 276 
were lysed with NaOH 0.5M and stored at –80°C for measuring total cellular protein 277 
amount in order to adjust cell adhesion molecules and chemokine measurements.  278 
In order to study the possible deconjugation of HT metabolites or conjugation of 279 
HT during the incubation with HEAC cells, the metabolite pattern in the cells and also 280 
in the culture media at the end of the incubation (24 h) was performed according to the 281 
same chromatographic method described  in Section 2.4. 282 
2.6. Cytotoxicity assays 283 
The cytotoxicity effect of HT (0-200 µM) on Caco-2 cells was tested using the 3-(4,5-284 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [24]. 200,000 285 
Caco-2 cells/mL were seeded in 24-multiwell plates and incubated with DMEM. After 286 
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24 hours, DMEM media was replaced with the same media enriched with different 287 
concentrations of the HT for 24 h at 37 °C and 5% CO2. Cells were then washed twice 288 
with PBS. DMEM enriched in 0.5 mg/mL of MTT (Sigma-Aldrich, Madrid, España), 289 
was added to each well and incubated for 3 h. To determine the formazan production, 290 
once supernatants discarded, cells were lysed using an extraction solution composed of 291 
DMSO and ethanol at a concentration of 1:1. A colorimetric assay was performed at 292 
570 nm optical density. 293 
The cytotoxicity effect of HT or HT metabolites on HAEC was assessed with a 294 
Cytotoxicity Detection Kit LDH (Roche Applied Science, Mannheim, Germany) as 295 
previously described [25]. For these experiments, TNF-α treatment was considered the 296 
maximum stress condition for the cells. The activity of the LDH released from the cells 297 
was measured in cell-free supernatants collected at the end of the experiment. Results 298 
are expressed as the mean optical density (OD: 492 nm) and standard deviation (SD; 299 
error bars) of LDH produced by the cells under each treatment condition.  300 
2.7. Total cellular protein quantification 301 
In order to adjust the soluble cell adhesion molecules (E-selectin, P-selectin, VCAM-1 302 
and ICAM-1) and chemokine (MCP-1) total cellular protein concentration from cell 303 
lysates was determined using the Bradford protein assay from Bio-Rad with bovine 304 
serum albumin (BSA). Standard concentrations of BSA were used as the calibration 305 
standards across the protein assay. The absorbance was measured at 595nm. The results 306 
were expressed in mg of total cellular protein per milliliter compared to the maximum 307 
stimulation with TNF-α (10 ng/mL). 308 
2.8. Measurement of soluble cell adhesion molecules and chemokine protein secretion 309 
by HAECs stimulated with TNF-α 310 
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Luminex® Performance Assay was used to determine VCAM-1, E-selectin, ICAM-1 311 
and P-selectin protein secretion and DuoSet® enzyme-linked immunosorbent assays 312 
(ELISA) was used to detect MCP-1/CCL2 chemokine protein secretion. Both protein 313 
detection kits were from R&D Systems (Vitro, Madrid, Spain) and the tests were 314 
conducted according to manufacturer’s protocol. 315 
All experimental data were compared to the outcomes in the TNF-α-alone 316 
incubation, since this achieved the maximal secretion of soluble cell adhesion molecules 317 
or chemokine. A vehicle-alone control (sterile H2O for HT or absolute methanol for HT 318 
metabolites) was run in parallel and used as the control in the experiments. Results are 319 
expressed as the percentage of soluble cellular adhesion molecules or chemokine 320 
protein secretion adjusted by total cellular protein and standard error of the mean (SEM; 321 
error bars) compared to the maximum stimulation with TNF-α (10 ng/mL). 322 
2.9. Statistical Analyses 323 
Unless otherwise stated, all experiments were performed at least twice and each 324 
incubation condition was set up in duplicate. One-way analysis of variance (ANOVA) 325 
followed by the Fisher's least significant difference (LSD) post-hoc test was used for 326 
multiple comparisons. A value of p < 0.05 was considered statistically significant. 327 
A requisite for the analytical quality of the model was the control of several aspects 328 
involved in the cellular process and analytical performance of measurements. Thus, we 329 
evaluated the precision of the model by calculating the SD, SEM and the coefficients of 330 
variation (CV). All the results were analyzed with the Statistical Package for the Social 331 
Sciences (SPSS) software (version 22.0). 332 
3. Results 333 
3.1. Cytotoxicity 334 
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Results from the Caco-2 MTT cytotoxicity assay showed that HT was not cytotoxic at 335 
doses from 50 to 150µM (data not shown). 336 
The cytotoxicity assay of the supernatants taken at the end of the study corresponding to 337 
the co-incubation of HT or HT metabolites at different concentrations (1, 2, 5 and 10 338 
µM) and TNF-α (10 ng/mL) for different exposure times (18 and 24 h), measured as the 339 
activity of LDH release showed no difference compared to the TNF-α (10 ng/mL) 340 
treatment alone, confirming that HT and HT metabolites are not cytotoxic at the 341 
concentrations and times tested (Figure S1 of  Supplementary Information). Lower 342 
concentrations of HT (<1µM) did not show any toxicity (Data not shown). 343 
3.2. Effect of Caco-2 cell pretreatment on HT metabolite production 344 
Table 1 shows the metabolism yield after exposing HT (100 µM) to different Caco-2 345 
cell pre-treatment models (A, B, C and D) at different exposure times (6, 12 and 24 h). 346 
Comparing the T75 flask and transwell treatments (A and B versus C and D, 347 
respectively), the results showed that HT was much less stable in transwell inserts and 348 
also showed less metabolic activity compared to cells cultured in T75 flasks. Regarding 349 
the different exposure times, the highest metabolic transformation was obtained after 24 350 
h. Longer exposure times were tested, but more than 24 h did not increase the 351 
metabolism yield and the total amount of metabolites obtained decreased with the time, 352 
probably due to a degradation process.  353 
Significant differences (p < 0.05) were observed on the biotransformation of HT 354 
into its main metabolites between the two T75 flasks models (A and B) at all-time 355 
points studied (6, 12 and 24 h), observing that Caco-2 cells under B treatment (21-days 356 
cultured cells) had a significantly higher metabolic activity compared to A treatment (3-357 
days cultured cells). These results confirmed that differentiated Caco-2 cells can exert a 358 
higher conjugation enzymatic activity (catechol-O-methyltransferase, UDP-359 
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glucuronosyltransferase and sulfotransferase) compared to non-differentiated cells and 360 
thus, they appeared to be a more appropriate approach to obtaining HT phase II 361 
metabolites. In the case of the transwell models, no significant differences were 362 
observed in the production of any HT metabolite when comparing C and D treatments. 363 
This could be attributed to the low enzymatic activity of the non-differentiated co-364 
cultured cells over the 3 days used in D treatment.  365 
Based on the biotransformation yield of HT into phase II metabolites, the 366 
differentiated cells in T75 flasks (B treatment) after 24 h of HT exposure was selected 367 
as the best approach to obtaining HT metabolites with the lowest concentration of 368 
residual free HT in the culture medium. Apart from being more efficient in terms of 369 
metabolic activity, T75 flasks are much cheaper, easier to handle and have a bigger 370 
surface compared to transwell inserts, which allows higher amounts of metabolites to be 371 
obtained. 372 
Moreover, different HT concentrations in the culture medium were assayed in order to 373 
test the effect of the initial HT concentration on its transformation yield into phase II 374 
metabolites.  Results showed that the metabolic transformation was similar in all 375 
concentrations tested (10, 15, 20, 25, 50, 100 µM) (Table S2 of Supplementary 376 
Information). Based on these results and considering that after the incubation of 100 377 
µM HT a major amount of HT metabolites was obtained, 100 µM HT was selected to 378 
produce the stock solution of HT metabolites. 379 
3.3. Effect of HT and HT metabolites on E-selectin, P-selectin, VCAM-1, ICAM-1 and 380 
MCP-1 protein secretion  381 
After 18 h of co-incubation, significant reductions were observed with HT at all tested 382 
doses in E-selectin levels (p<0.05), with reductions ranging from 32.7 to 45.9% 383 
compared to TNF-α alone. HT metabolites significantly reduced E-selectin protein 384 
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secretion by 36.6% (p<0.05) only at 10 µM (Table S3 and Figure S2 of 385 
Supplementary Information).  386 
After 24 h of co-incubation the reduction trend observed at 18 h was confirmed. 387 
HT reduced E-selectin, P-selectin, VCAM-1 and ICAM-1 at all tested doses (1, 2, 5 and 388 
10 µM) compared to TNF- α alone (p<0.05) but the reductions did not follow a dose-389 
dependent response (Figure 2). HT metabolites reduced E-selectin, P-selectin, VCAM-390 
1 and ICAM-1 at 2, 5 and 10 µM and additionally, they also reduced MCP-1 391 
significantly at 5 and 10 µM compared to TNF-α alone. In this case, the molecules were 392 
reduced in a dose-dependent manner (p<0.05; Figure 2).  393 
It is noteworthy that at 10 µM, HT metabolites were more effective than HT at 394 
reducing E-selectin, P-selectin, VCAM-1, ICAM-1 and MCP-1 with respective 395 
reductions of 62.4, 61.9, 55.4, 57.0 and 39.0% compared to HT (53.6, 48.6, 48.7, 40.6 396 
and 11.7 %, respectively (Figure 2 and Table S3 of Supporting Information). 397 
However, these reductions in HT metabolites compared to HT were only significant for 398 
the MCP-1 molecule. 399 
To exclude the effects of the residual HT present in the HT metabolite mixture, 400 
lower concentrations of HT (0.9, 0.45, 0.18 and 0.09 µM) equivalent to the 9% of the 401 
tested doses of HT metabolites (10, 5, 2 and 1 µM, respectively) were tested to evaluate 402 
the possible activity of the residual concentration of free HT (Figure 3). Results showed 403 
that concentrations of 0.45 and 0.9 µM were effective in the reduction of VCAM-1, 404 
ICAM-1, P-selectin and E-selectin indicating that the activity of the metabolite mixture 405 
could be due in part to the residual HT in the case of the highest doses (5 and 10 µM). 406 
However, when testing 0.18 µM HT any significant effect was observed in the 407 
inhibition of the adhesion molecules, whereas the concentration of 2 µM of the HT 408 
metabolites mixture exerted a significant effect in the reduction of all adhesion 409 
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molecules. The reduction percentages observed after testing 0.45 and 0.9 µM of HT 410 
were 10% lower compared to their respective HT metabolites mixtures (10 and 5 µM). 411 
These results indicate that HT metabolites are in part responsible for the attenuation of 412 
the inflammation-induced expression of adhesion molecules. In the case of the 413 
chemokine MCP-1, lower concentrations assays confirmed that HT has no effect on 414 
reducing MCP-1 at any concentration. 415 
Vehicle control condition for HT (sterile H2O) or HT metabolites (absolute 416 
methanol) are not shown due to their low values of E-selectin, P-selectin, VCAM-1, 417 
ICAM-1 and MCP-1 protein secretion concentrations. They were not within the limits 418 
of detection of the techniques used for determining these molecules in this study, so 419 
they were assumed as practically zero. 420 
3.4. Analysis of HT and metabolites in cells and culture media after incubation 421 
The metabolite pattern in the cells and also in the medium at the end of the 422 
incubation was analysed. Unexpectedly, results showed that after 24 h of incubation 423 
with HT, the native compound underwent a conjugation process leading to its main 424 
metabolites in a dose-dependent manner (Figure 4), revealing that HEAC cells have 425 
conjugation enzymatic capabilities, mainly catechol-O-methyltransferase and 426 
sulfotransferase activity (Table S4 Supplementary Information). On the other hand, 427 
after incubating the HT metabolite mixture with HEAC cells, small amounts of free HT 428 
were detected in cells and HT did not increase in parallel to the tested dose, indicating 429 
that the metabolites were not hydrolysed in cells during the assay and probably HT was 430 
degraded during incubation. Results from culture media presented a very similar profile 431 
compared to cells (Figure 4).  432 
4. Discussion 433 
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 The present study is among the first to obtain a mixture of physiological phase II 434 
metabolites of HT and demonstrating that they are able to exert an effect in the 435 
reduction of the endothelial dysfunction biomarkers in an in vitro endothelial cell model 436 
at plasmatic concentrations achievable following ingestion of olive oil [10]. The 437 
remaining amount of unaltered HT in urine is very low (<1%) [8,11] and undetectable 438 
in plasma after the consumption of nutritional amounts of VOO phenols and, therefore, 439 
the role of HT phase II metabolites in preventing atherosclerosis must be considered. 440 
However, in vitro studies with endothelial cell models carried out to date used HT 441 
[26,27] rather than the majority forms that appear in human plasma.  442 
So, in order to perform mechanistic studies, firstly, it is necessary to obtain the 443 
HT metabolites, which are not commercially available. For this proposal, in the present 444 
study Caco-2 cells were incubated with HT in order to produce a mixture of HT 445 
metabolites resembling the human plasma after the intake of virgin olive oil. Previous 446 
studies have used different approaches to obtaining phase II metabolites of phenolic 447 
compounds [28–31]. The chemical synthesis approach could be considered the cheapest, 448 
but its main drawback is that most chemical procedures yield mixtures of α- and β–449 
anomers along with side-products [32]. Biocatalysis-assisted synthesis using tissue 450 
homogenates or recombinant conjugating enzymes (glucuronosyltransferases and 451 
sulfotransferases) is an alternative strategy for preparing phenolic conjugates [33]. 452 
However, enzymatic synthesis requires the use of either expensive enzymes, co-factors 453 
(uridine 5'-diphospho-glucuronic acid and adenosine-5'-phosphosulfate) or liver 454 
microsomes and the degree of conversion is also very low [28]. Another alternative 455 
could be the use of biological samples to obtain phenolic phase II metabolites, which 456 
have been reported previously for the isolation of resveratrol glucuronide conjugates 457 
from human urine [30], thymol sulfate from rat urine [29] or catechin and quercetin 458 
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from rat plasma [31]. The main drawback of this approach is that it requires the 459 
performance of an in vivo study and the amounts obtained are very small. 460 
 In relation to VOO phenolic metabolites, a previous study attempted to 461 
synthetize HVAlc and the glucuronic forms of HT using porcine liver microsomes [34]. 462 
In another study the potential hepatic metabolism of VOO phenolic compounds by 463 
HepG2 cell lines was tested, and the glucuronide, methylglucuronide, and methyl 464 
conjugates of HT were the main metabolites produced [35]. In both studies no sulfate 465 
conjugates were produced, which could be attributed to the low sulfotransferase activity 466 
of HepG2 cell line and its very low/partial expression of cytochrome P-450 [36]. Our 467 
previous studies in humans indicate that sulfation constitutes the major pathway for HT 468 
metabolism in humans [9,10], and up to date, any effective and simple strategy to obtain 469 
a pool of the real phase II circulating HT metabolites has been developed.  470 
In the present study, we demonstrate that the use of Caco-2 cells as bioreactors 471 
for the generation of phase II metabolites of HT is a very appropriate tool given their 472 
availability, long life-span, stable phenotype, high metabolic efficiency, ease of 473 
handling and the fact that they do not require the use of human volunteers or animals. 474 
Caco-2 cells, which are usually used as a model for studying the intestinal transport and 475 
metabolism of some dietary compounds [37], are obtained from human colon 476 
adenocarcinoma and spontaneously differentiate in a confluence culture as intestinal 477 
absorptive cells due to changes in their morphology [38]. Once they are differentiated, 478 
Caco-2 cells exert phase II conjugate enzymes and cytochrome P-450 isoforms, and are 479 
useful for studying their metabolic activity and characterizing human circulating 480 
metabolites, as reported in previous studies in which the metabolic profile was 481 
determined after a polyphenol exposure [7,37].  482 
This approach also allowed to obtain a metabolic profile very similar to the 483 
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human plasma after the consumption of nutritional amounts of VOO phenols [10]. In 484 
this previous study the main metabolites detected in plasma after a sustained intake of 485 
25 mL of VOO with high phenolic content (500 mg total phenolic compounds/ kg oil) 486 
were the sulfated forms of HT (79%), homovanillic alcohol sulfate (sulfHVAlc) (19%), 487 
and in a minor proportion the homovanillic acid sulfate (sulfHVac). The Caco-2 488 
intestinal cell model allowed us obtaining a mixture in which the main metabolites were 489 
HTsulf (80%), sulfHVAlc (10%) and in a minor proportion, HT glucuronides and free 490 
HT (Figure 5). So the obtained mixture of metabolites is very close to the previously 491 
observed human plasma profile, with a 90% of resemblance. 492 
Results from the TNF-α stimulated HAEC cells indicated that after 24 h of 493 
incubation both HT metabolites and free HT at physiological concentrations (1 to 10 494 
µM) were effective at reducing E-selectin, P-selectin, VCAM-1 and ICAM-1 molecules 495 
involved at the first stages of atherosclerosis. In a previous study the inhibition of 496 
endothelial activation by free HT was described in a human umbilical vein endothelial 497 
cell (HUVEC) model, observing that HT was able to reduce lipopolysaccharide (LPS)-498 
stimulated expression of VCAM-1 at low micromolar concentrations [15]. Another 499 
study observed reductions in E-selectin, VCAM-1 and ICAM-1 after HT exposure on 500 
HUVEC at doses of 5 and 25 µM of HT. [39]. Regarding MCP-1, Richard N et al. also 501 
observed a significant reduction of MCP-1 after HT exposure (25µM) on murine 502 
macrophages (RAW264.7 cells) [40]. In the two latter studies, the effect of HT 503 
metabolites was not tested, so the physiological significance of the results is 504 
questionable. 505 
 After the HT treatments we also observed that the remaining amounts of free 506 
HT in the cells and media did no differ significantly among the tested doses, which was 507 
in accordance with the observed effects in the modulation of the cell adhesion 508 
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molecules that were also maintained regardless of the dose. However, when HT 509 
metabolites were incubated with HAEC cells, an increasing concentration of these 510 
metabolites was detected in the cells with a parallel dose-dependent inhibition. These 511 
data provide evidence of the potential effect of HT phase II metabolites in the reduction 512 
of the endothelial dysfunction biomarkers. 513 
The residual amount of free HT in the obtained metabolite mixture represents 514 
the major difference with the plasma data. Therefore, in order to test the possible 515 
activity of the residual amounts of HT present in the metabolite mixtures, lower 516 
concentrations were tested. Results indicated that in the case of adhesion molecules 517 
(VCAM-1, ICAM-1, E-selectin and P-selectin) the attenuation effect of the metabolite 518 
mixtures could be due to a large extent to the residual HT. However, in all cases, 519 
reductions of the metabolite mixtures were 10% greater compared to their 520 
corresponding amounts of residual HT, indicating that metabolites also contribute in the 521 
inhibition. The effect of the metabolites was confirmed when the dose of 2 uM HT 522 
metabolites was tested, observing a significant inhibition of all adhesion molecules 523 
secretion, whereas its corresponding percentage of residual HT did not show any effect. 524 
From these results it can be concluded that metabolites might be in part responsible for 525 
the attenuation of the inflammation-induced expression of adhesion molecules.  526 
In the case of the chemokine MCP-1, HT did not show any effect at any tested 527 
dose, whereas the highest doses (5 and 10 µM) of HT metabolites presented a 528 
significant effect, indicating in this case that metabolites clearly seem to be active on the 529 
inhibition of the secretion of this chemokine. The specific effect of HT metabolites on 530 
reducing MCP-1 could also indicate that free HT and HT metabolites could act reducing 531 
the endothelial dysfunction through different endpoints and having complementary 532 
activities. 533 
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Unexpectedly, after the incubation assays with HT, an important amount of HT 534 
metabolites were detected in the cells and media, most of them sulfo and methylsulfo-535 
conjugated. Catechol-O-methyltransferase (COMT) have been previously described in 536 
endothelial cells after incubating HUVEC with ()-epicatechin, identifying the 537 
endothelial NADPH oxidase as a specific candidate target for the methylated forms 538 
[41]. SULT1A1, the main sulfotransferase enzyme responsible for the detoxification of 539 
xenobiotics, has been found in many different human tissues, with the highest 540 
abundance found in the liver, but it has never been detected in human aortic endothelial 541 
cells. Thus, the data provided in the present work add value to the study suggesting that 542 
aortic sulfotransferases may play an important role in reducing local cellular 543 
concentrations of native forms of phenolic compounds.  544 
Although phase II phenolic metabolites have been generally considered to be 545 
pharmacologically inactive and targets for excretion [42], our results indicate that the 546 
inhibition of the endothelial dysfunction could be partly due to the HT metabolites. The 547 
effect of flavonoids (quercetin and (+)-catechin) and their different conjugates on cell 548 
adhesion has been recently reviewed [43] and it was established that conjugation can 549 
significantly affect the activity of aglycones both reducing and increasing the effects. 550 
So, given that the effects of conjugation can differ greatly on cell adhesion, research on 551 
the biological activity has to be done on a case-by-case basis. 552 
Our results also demonstrate that effects other than the reduction of ox-LDL and 553 
cholesterol, which have been demonstrated in humans [1,44–46], may explain the anti-554 
atherogenic action of VOO phenolic compounds. Two additional mechanisms involved 555 
in the vascular damage, platelet aggregation and proliferation of smooth muscle cells, 556 
are also antagonized by the VOO phenolic compounds, it was particularly observed that 557 
HT inhibits in vitro platelet aggregation induced by thromboxane B2 production and 558 
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collagen [16]. 559 
5. Conclusions 560 
This is the first time that HT metabolites have been synthetized by using a 561 
differentiated Caco-2 cell line, obtaining a purified extract that resembles the human 562 
plasma HT metabolite profile after VOO intake. Results indicate that both free HT and 563 
HT metabolites are effective in the reduction of the endothelial dysfunction biomarkers 564 
but only HT metabolites reduce MCP-1 at physiological doses. Novel data is presented 565 
regarding the presence of xenobiotic detoxification enzymes in HAEC cells, which add 566 
value to the study suggesting that catechol-O-methyltransferase and sulfotransferases 567 
may play an important role in reducing local cellular concentrations of native forms of 568 
phenolic compounds in aortic endothelial cells. Our data suggest that HT metabolites 569 
might be the responsible in part for the protection against endothelial dysfunction, and 570 
thus they are likely to contribute to the reduced risk in the early stages of 571 
atherosclerosis, which provide a clear future direction in olive oil phenols research.  572 
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Figure captions 577 
Figure 1. Caco-2 cell culture treatments for HT metabolites production and the 578 
methodology used for their extraction and purification. A: Caco-2 cell culture 579 
treatments tested to obtain HT metabolites. T75 flask and transwell inserts were used as 580 
two different culture conditions to obtain HT metabolites with different differentiation 581 
states and at different times of HT exposure (6, 12 and 24h). B: procedure for the 582 
extraction and purification of HT metabolites from Caco-2 cells supernatants. 583 
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Figure 2. Effect of HT and HT metabolites on E-selectin, P-selectin, VCAM-1, ICAM-584 
1 and MCP-1 protein secretion in HAEC stimulated by TNF-α after 24h. 585 
HAEC were co-incubated with HT or HT metabolites at 1, 2, 5 and 10 µM and TNF-α 586 
(10 ng/mL) for 24h. A) Effect of HT or HT metabolites on E-selectin protein secretion. 587 
B) Effect of HT or HT metabolites on P-selectin protein secretion.  C) Effect of HT or 588 
HT metabolites on VCAM-1 protein secretion. D) Effect of HT or HT metabolites on 589 
ICAM-1 protein secretion. E) Effect of HT or HT metabolites on MCP-1 protein 590 
secretion. Results are expressed as the percentage of soluble cellular adhesion molecules 591 
or chemokine protein secretion adjusted by total cellular protein and standard error of 592 
the mean (SEM; error bars).  * p < 0.05 versus TNF-α alone. † p < 0.05 compared 593 
between HT and HT metabolites at the same concentration. 594 
Figure 3. Effect of HT at lower concentrations (<1 µM) on E-selectin, P-selectin, 595 
VCAM-1, ICAM-1 and MCP-1 protein secretion in HAEC stimulated by TNF-α after 596 
24h.The tested concnetrations (0.9, 0.45, 0.18 and 0.09 µM) were equivalent to the 9% 597 
of the tested doses of HT metabolites (10, 5, 2 and 1 µM). 598 
Figure 4. HT and metabolites in HAEC cells and culture media after co-incubation with 599 
HT or HT metabolites at 1, 2, 5 and 10 µM and TNF-α (10 ng/mL) for 24h.  600 
Figure 5. HT metabolites profile in human plasma versus Caco-2 cell production. 601 
Extracted ion chromatograms in human plasma after a sustained intake of virgin olive 602 
oil and in purified extract obtained from Caco-2 exposed to HT (differentiated cells in 603 
flasks / 24 h exposure of HT 100 µM). 604 
Supporting information. 605 
Figure S1. Cytotoxicity from HAEC’ supernatants after co-incubation with HT or HT 606 
metabolites and TNF-α. HAEC were co-incubated with HT (A) or HT metabolites (B) 607 
at 1, 2, 5 and 10 µM and TNF-α (10 ng/mL) for 18 and 24 h. Vehicle control refers to 608 
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cells incubated with HT vehicle (H2O) or HT metabolites vehicle (MetOH). Results are 609 
expressed as the mean and the SD (error bars) of optical density (OD; 492 nm) from one 610 
representative experiment where each set of experimental conditions was run in 611 
duplicate. *P<0.05 compared to maximum stimulation TNF-α alone.  612 
Figure S2. Effect of HT and HT metabolites on E-selectin, P-selectin, VCAM-1, 613 
ICAM-1 and MCP-1 protein secretion in HAEC stimulated by TNF-α after 18h.  614 
HAEC were co-incubated with HT or HT metabolites at 1, 2, 5 and 10 µM and TNF-α 615 
(10 ng/mL) for 18h. A) Effect of HT or HT metabolites on E-selectin protein secretion. 616 
B) Effect of HT or HT metabolites on P-selectin protein secretion.  C) Effect of HT or 617 
HT metabolites on VCAM-1 protein secretion. D) Effect of HT or HT metabolites on 618 
ICAM-1 protein secretion. E) Effect of HT or HT metabolites on MCP-1 protein 619 
secretion. Results are expressed as the percentage of soluble cellular adhesion molecules 620 
or chemokine protein secretion adjusted by total cellular protein and standard error of 621 
the mean (SEM; error bars).  * p < 0.05 versus TNF-α alone. † p < 0.05 compared 622 
between HT and HT metabolites at the same concentration. 623 
624 
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Table 1. HT and its metabolites concentration (µM) in culture media after HT exposure among different Caco-2 cell pretreatment models (T75 flask or transwell inserts) at 
different times of exposure (6, 12 and 24h). A: 3-day cultured cells in T75 flasks; B: 21-day cultured cells in T75 flasks; C: 21-day cultured cells in the apical side of transwell inserts 
and D: 18-day cultured cells in the apical side plus 3-day co-cultured cells in the basolateral side of transwell inserts (21 days in total). For treatments C and D values were the sum of 
apical and basolateral sides. The initial concentration of HT in culture media for all the experiments was 100µM. Based on the yield transformation of HT into phase II metabolites, the 
differentiated cells in flasks (B treatment) after 24 h of HT exposure were selected as the best approach. 
HT: hydroxytyrosol; sulfHT: hydroxytyrosol sulfate; 4-GluHT: hydroxytyrosol 4’ glucuronide; 3-GlucHT: hydroxytyrosol 3’ glucuronide; sulfHVac: homovanillic acid sulfate; glucHVac: homovanillic acid 
glucuronide; sulfHVAlc: homovanillic alcohol sulfate; glucHVAlc: homovanillic alcohol glucuronide. 
n.d.: not detected; n.q.: not quantified 
 
Different superscript letters (a,b,c) mean significant differences between treatments (A,B, C and D) in the same time tested for each metabolite. 
 
One-way Analysis of variance (ANOVA) followed by the Fisher's least significant difference (LSD) post-hoc test was used for multiple comparisons (p< 0.05). 
 
* Quantified by using the calibration curve of HT. 
** Quantified by using the calibration curve of HT-3-O-sulfate. 
 
 
Concentration 
(µM) 
6 h  12 h  24 h 
T75 FLASK TRANSWELL  T75 FLASK TRANSWELL  T75 FLASK TRANSWELL 
A B C D 
 
A B C D  A B C D 
HT * 76.10 ± 10,60
a
 66.47 ± 10.47
b
 41.87 ± 10.25
c
 23.52 ± 9.81
c
  45.15 ± 15.71
a
 39.20 ± 5.24
 b
 9.29 ± 3.04
 c
 13.90 ± 1.53
 c
  39.91 ± 1.32
 a
 6.98 ± 0.20
 b
 5.18 ± 3.77
 b
 5.25 ± 0.33
 b
 
sulfHT ** 0.11 ± 0.00
 a
 10.77 ± 0.88
 b
 10.08 ± 3.02
 b
 10.37 ± 3.30
 b
  0.63 ± 0.77
 a
 27.73 ± 3.57
 b
 758 ± 2.62
 c
 7.27 ± 3.58
 c
  2.33 ± 0.83
 a
 63.42 ± 9.23
 b
 8.00± 2.44
  c
 7.99 ± 1.33
 c
 
 4-GlucHT* n.d. 0.19 ± 0.04 1.03 ± 0.63 1.08 ± 0.72  n.d. 0.48 ± 0.19 0.62 ± 0.40 0.62 ± 0.35  0.13 ± 0.03
 a
 0.60 ± 0.13
 b
 0.64 ± 0.43
 b
 0.76 ± 0.39
 b
 
 3-GlucHT* n.d. 0.06 ± 0.03 0.03 ± 0.01 0.04 ± 0.02  n.d. 0.10 ± 0.11
 a
 0.01 ± 0.01
 b
 0.02 ± 0.01
b
  0.02 ± 0.01
 a
 0.31 ± 0.06
 b
 0.02 ± 0.01
a
 0.03 ± 0.00
 b
 
sulfHVac* n.q. n.q. 0.08 ±  0.02 0.07 ± 0.04  n.q. n.q. 0.06 ± 0.03 0.07 ± 0.06  n.q. 0.06 ± 0.04 0.03 ± 0.01 0.03 ± 0.01 
glucHVac* n.d. n.d. 0.02 ± 0.02 0.03 ± 0.04  n.d. n.d. 0.04 ± 0.02 0.03 ± 0.01  n.d. 0.01 ± 0.01 0.02 ± 0.01 0.02 ± 0.00 
sulfHVAlc * 0.03 ± 0.00 
a
 0.28 ± 0.02
 b
 0.03 ± 0.00
 a
 0.05 ±0.02
 a
  0.02 ± 0.00 n.q. 0.03 ± 0.02 0.02 ±0.02  0.02 ± 0.02
 a
 2.27 ± 0.48
 b
 0.01 ± 0.00
 a
 0.02 ± 0.02
 a
 
glucHVAlc* n.q. 0.11 ± 0.02* n.q. n.q.  n.q. 0.35 ± 0.08 n.q. n.q.  n.q. 0.29 ± 0.16 n.q. n.q. 
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